Trial Profile
Efficacy and Safety of Synera in OA Pain
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 14 May 2015
Price :
$35
*
At a glance
- Drugs Lidocaine/tetracaine (Primary)
- Indications Musculoskeletal pain
- Focus Therapeutic Use
- 11 May 2015 Status changed from active, no longer recruiting to completed, according to to ClinicalTrials.gov record.
- 01 Sep 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 03 Apr 2013 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.